HOME >> MEDICINE >> NEWS
Blood clots can be treated by injections at home

Treatment of blood clots in the deep veins of the legs or the lungs with an older, less expensive form of the anticoagulant medication heparin can be just as safe and effective as similar treatment with a newer and more expensive heparin, according to a study led by Clive Kearon, professor of medicine at McMaster University, published in the August 23 issue of JAMA (The Journal of the American Medical Association).

When injected subcutaneously (beneath the skin), unfractionated (regular) heparin was shown in a randomized trial to work just as well as subcutaneous injection of the more expensive, low-molecular weight heparin in the treatment of venous thromboembolism. Traditionally, when unfractionated heparin is used in treatment, it is administered intravenously and accompanied by coagulation monitoring, which requires hospitalization. This standard approach includes ongoing dose adjustment in response to measurement of the APTT, a test that measures how fast the blood clots in a test tube under certain conditions.

The newer low-molecular weight heparins, which are administered by injection in fixed-weight doses, have gradually been replacing unfractionated heparin.

Kearon and colleagues conducted a randomized trial to study how fixed-dose, subcutaneous injection of unfractionated heparin compared to injection with the newer heparin in the treatment of blood clots in the legs or lungs.

The study was conducted from September 1998 through February 2004 at six university-affiliated clinical centres in Canada and New Zealand. Patients in the trial received either unfractionated or low-molecular-weight heparin administered subcutaneously every 12 hours. About 70 per cent of both groups were treated as outpatients. All patients received three months of warfarin (an anticoagulant drug) therapy.

Recurrent thromboembolism occurred in 3.8 per cent of the 345 patients in the unfractionated heparin group, and in 3.4 perce
'"/>

Contact: Veronica McGuire
vmcguir@mcmaster.ca
90-552-591-402-2169
McMaster University
22-Aug-2006


Page: 1 2

Related medicine news :

1. Blood inflammation plays role in Alzheimers disease
2. Blood-thinning drugs need closer monitoring
3. Blood transfusions from precancerous blood donors do not increase risk of cancer
4. Blood marker helps predict prognosis among those with abdominal infection
5. Blood transfusions raise heart patients infection and death risk -- especially women
6. Blood pressure drugs could help halt pancreatic cancer spread, Jefferson researchers find
7. Blood cells linked to heart attacks, other inflammatory diseases
8. Blood transfusion-transmitted infections: A global perspective
9. Blood pressure variability increases risk for stroke death
10. Blood pressure drugs associated with reduced risk of esophageal, pancreatic and colon cancers
11. Canadian Blood Services scientist invents potential alternative for high-demand blood product

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/26/2020)... ... May 26, 2020 , ... Sex educator, activist, humanitarian, ... advocate Joan Price have just received the 2020 AASECT Audio Visual Award for jessica ... was the first of its kind to feature non-actors in its demonstrations and narratives ...
(Date:5/21/2020)... , ... May 21, 2020 ... ... Companion to the CRC’s Guide to Coordinating Clinical Research, CenterWatch eLearning , ... research management, The CRC Trainer: An Interactive Companion to the CRC’s Guide ...
(Date:5/21/2020)... (PRWEB) , ... May 21, 2020 , ... ... and an industry leader in cancer biomarker assays, announced today that Cigna has ... Cigna Corporation is a global health service company dedicated to improving the health, ...
(Date:5/21/2020)... ... , ... Friends of Lisa Campbell, announce that Lisa Campbell, candidate for the ... Advocates (PPSEA). PPSEA educates and lobbies on behalf of women’s health and ... health care. PPSEA educates and lobbies on behalf of women’s health and works to ...
(Date:5/21/2020)... , ... May 21, 2020 , ... The Rise of ... have been a lot of complications and adjustments, needless to say, more complications. With ... level since the great depression it can be hard to escape and find peace. ...
Breaking Medicine News(10 mins):
(Date:6/4/2020)... ... June 04, 2020 , ... One minute it was business as usual, ... the lexicon. COVID-19 turned the world on its head, and everything ground to a ... AutismOne annual conference went from a physical event to a virtual one in seven ...
(Date:6/3/2020)... ... June 03, 2020 , ... Axiom Medical, a longtime leader ... CheckIn2Work app, a first of its kind technology providing workplace point-of-entry protection and ... quick and easy self-service health attestation for organizations needing to pre-screen team members ...
(Date:6/2/2020)... ... June 02, 2020 , ... ... of cancers with the watershed FDA approvals of two Chimeric Antigen Receptor T-Cell ... have emerged including modified T-cell receptor T-cells (TCR-Ts), Natural Killer (NKs) cells and ...
Breaking Medicine Technology:
Cached News: